Advertisement

Topics

Ameparomo Capsules 250 mg Drug Use Investigation

2016-02-15 21:02:47 | BioPortfolio

Summary

This Study is intended to evaluate the safety and effectiveness of Ameparomo Capsules 250 mg under actual medical practice.

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Conditions

Intestinal Amebiasis

Status

Enrolling by invitation

Source

Pfizer

Results (where available)

View Results

Links

Published on BioPortfolio: 2016-02-15T21:02:47-0500

Clinical Trials [227 Associated Clinical Trials listed on BioPortfolio]

Study of Nitazoxanide in the Treatment of Amebiasis in Children

The purpose of this study is to determine the effect of nitazoxanide suspension in treating diarrhea caused by Entamoeba histolytica in children.

Study of Nitazoxanide in the Treatment of Amebiasis in Adults and Adolescents

The purpose of this study is to determine the effect of nitazoxanide tablets in treating diarrhea caused by Entamoeba histolytica in adults and adolescents.

Effects of Comprehensive Intestinal Protection Strategy on Postoperative Intestinal Complications

To investigate the morbidity of intestinal injury after open surgery and observe the effect of comprehensive intestinal protection strategy on postoperative intestinal complications in pat...

Intestinal Protozoal Infections and Sexual Transmitted Diseases Among Targeted Cohorts

In this two-year study, we will target two high risk groups, including MSM of HIV-infected and those of non-HIV-infected. We will avail the serodiagnosis to detect the potential amebic car...

Proteomic Analysis Reveals Innate Immune Activity In Intestinal Transplant Dysfunction

Many patients with intestinal failure require intestinal transplantation for survival. Currently, the gold standard for diagnosing acute cellular rejection (ACR) is histological examinatio...

PubMed Articles [1511 Associated PubMed Articles listed on BioPortfolio]

Case Report: Endemic Amebiasis in Australia: Implications for Residents, Travelers, and Clinicians.

Entamoeba histolytica is considered endemic in Australia; however, cases are rare, occurring almost exclusively in high-risk individuals. We describe a series of locally acquired, complicated cases in...

A case of amebiasis with negative serologic markers that caused intra-abdominal abscess.

A 23-year-old Japanese woman presented with abdominal distention following fever, diarrhea, and abdominal pain during a stay in Taiwan. Serology for the detection of amebic-antibodies and stool micros...

Dysbiosis of intestinal microbiota and decrease in paneth cell antimicrobial peptide level during acute necrotizing pancreatitis in rats.

Intestinal barrier dysfunction plays an important role in acute necrotizing pancreatitis (ANP) and intestinal microbiota dysbiosis was involved in intestinal barrier failure. Paneth cells protect inte...

Alcohol injury damages intestinal stem cells.

Alcohol consumption is associated with intestinal injury including intestinal leakiness and the risk of developing progressive gastrointestinal cancer. Alcoholics have disruption of intestinal barrier...

Intestinal failure due to short bowel syndrome: impact of a multidisciplinary intestinal rehabilitation program.

In patients suffering intestinal failure due to short bowel, the goal of an Intestinal Rehabilitation Program is to optimize and tailor all aspects of clinical management, and eventually, wean patient...

Medical and Biotech [MESH] Definitions

A condition caused by the lack of intestinal PERISTALSIS or INTESTINAL MOTILITY without any mechanical obstruction. This interference of the flow of INTESTINAL CONTENTS often leads to INTESTINAL OBSTRUCTION. Ileus may be classified into postoperative, inflammatory, metabolic, neurogenic, and drug-induced.

Dilatation of the intestinal lymphatic system usually caused by an obstruction in the intestinal wall. It may be congenital or acquired and is characterized by DIARRHEA; HYPOPROTEINEMIA; peripheral and/or abdominal EDEMA; and PROTEIN-LOSING ENTEROPATHIES.

Agents which are destructive to amebae, especially the parasitic species causing AMEBIASIS in man and animal.

A highly basic, 28 amino acid neuropeptide released from intestinal mucosa. It has a wide range of biological actions affecting the cardiovascular, gastrointestinal, and respiratory systems and is neuroprotective. It binds special receptors (RECEPTORS, VASOACTIVE INTESTINAL PEPTIDE).

A twisting in the intestine (INTESTINES) that can cause INTESTINAL OBSTRUCTION.

More From BioPortfolio on "Ameparomo Capsules 250 mg Drug Use Investigation"

Quick Search
Advertisement
 

Searches Linking to this Trial